MedPath
HSA Approval

Artesunate Amivas Powder and Solvent for Solution for Injection 110mg/vial

SIN17135P

Artesunate Amivas Powder and Solvent for Solution for Injection 110mg/vial

Artesunate Amivas Powder and Solvent for Solution for Injection 110mg/vial

November 11, 2024

ACX HEALTH PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantACX HEALTH PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

P01BE03

Manufacturer Information

ACX HEALTH PTE. LTD.

Dalton Chemical Laboratories Inc. O/A Dalton Pharma Services

Active Ingredients

Artesunate

110mg/vial

Artesunate

Documents

Package Inserts

Artesunate Amivas Powder and Solvent for Injection 110mg PI.pdf

Approved: November 11, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.